Investigative Urology - Results from #6240

Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells - Abstract April 3, 2012

Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride - Abstract April 3, 2012

The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor - Abstract April 3, 2012

Current status of molecular markers for prognostication and outcome in invasive bladder cancer - Abstract April 2, 2012

Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer - Abstract April 2, 2012

A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer - Abstract April 2, 2012

Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder - Abstract April 2, 2012

The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway - Abstract April 2, 2012

Demonstrating the importance of polymer-conjugate conformation in solution on its therapeutic output: Diethylstilbestrol (DES)-polyacetals as prostate cancer treatment - Abstract March 30, 2012

Transcriptomic alterations in human prostate cancer cell LNCaP tumor xenograft modulated by dietary phenethyl isothiocyanate - Abstract March 29, 2012

The dark side of mast cell-targeted therapy in prostate cancer - Abstract March 29, 2012

Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line - Abstract March 29, 2012

Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells - Abstract March 29, 2012

Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression - Abstract March 29, 2012

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases - Abstract March 29, 2012

Genetic variants associated with predisposition to prostate cancer and potential clinical implications - Abstract March 28, 2012

DNA methylation silences miR-132 in prostate cancer - Abstract March 28, 2012

Characterization of hydrogen sulfide and its synthases, cystathionine β-synthase and cystathionine γ-lyase, in human prostatic tissue and cells - Abstract March 28, 2012

Glycine transporter type 2 (GlyT2) inhibitor ameliorates bladder overactivity and nociceptive behavior in rats - Abstract March 28, 2012

Therapeutic effect of combination of alagebrium (ALT-711) and sildenafil on erectile function in diabetic rats - Abstract March 28, 2012

Page 313 of 346